Evidence map›Paper›PMID 33584691›Full record

ArticleFrontiers in immunology2020

The Influence of B Cell Depletion Therapy on Naturally Acquired Immunity to

Giuseppe Ercoli, Elisa Ramos-Sevillano, Rie Nakajima, Rafael Ramiro de Assis, Algis Jasinskas, David Goldblatt, Philip Felgner, Gisbert Weckbecker, Jeremy Brown

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Naturally acquired adaptive immunity toClinical & translational immunology · 2024
    Article
  10. Article
  11. Maintained partial protection againstClinical & translational immunology · 2022
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Giuseppe ErcoliCentre for Inflammation and Tissue Repair, UCL Respiratory, Division of Medicine, University College Medical School, Rayne Institute, London, United Kingdom.
Elisa Ramos-SevillanoCentre for Inflammation and Tissue Repair, UCL Respiratory, Division of Medicine, University College Medical School, Rayne Institute, London, United Kingdom.
Rie NakajimaVaccine Research and Development Center, Department of Physiology and Biophysics, University of California Irvine, Irvine, CA, United States.
Rafael Ramiro de AssisVaccine Research and Development Center, Department of Physiology and Biophysics, University of California Irvine, Irvine, CA, United States.
Algis JasinskasVaccine Research and Development Center, Department of Physiology and Biophysics, University of California Irvine, Irvine, CA, United States.
David GoldblattDepartment of Immunobiology, UCL Great Ormond Street Institute of Child Health, NIHR Biomedical Research Centre, London, United Kingdom.
Philip FelgnerVaccine Research and Development Center, Department of Physiology and Biophysics, University of California Irvine, Irvine, CA, United States.
Gisbert WeckbeckerNovartis Institute for BioMedical Research, Novartis, Basel, Switzerland.
Jeremy BrownCentre for Inflammation and Tissue Repair, UCL Respiratory, Division of Medicine, University College Medical School, Rayne Institute, London, United Kingdom.
University of California, Irvine · USUniversity College London · GBNovartis Institutes for BioMedical ResearchUCL Biomedical Research Centre · GB

Funding

Department of HealthMedical Research Council MR/N02687X/1Medical Research Council MR/R001871/1
6 · The paper itself

Abstract

The anti-CD20 antibody Rituximab to deplete CD20+ B cells is an effective treatment for rheumatoid arthritis and B cell malignancies, but is associated with an increased incidence of respiratory infections. Using mouse models we have investigated the consequences of B cell depletion on natural and acquired humoral immunity to

Indexed as

Immunity, HumoralImmunity, InnateLymphocyte DepletionAnimalsAntibodies, BacterialB-LymphocytesDisease Models, AnimalFemaleHost-Pathogen InteractionsImmunity, CellularImmunoglobulin GImmunoglobulin MImmunologic FactorsMiceMice, Inbred C57BLPneumonia, PneumococcalAntibodies, BacterialImmunoglobulin GImmunoglobulin MImmunologic FactorsRituximabanti-protein antibodyB cell depletionCD20colonizationStreptococcus pneumoniae

Identifiers

PMID33584691
PMCPMC7876223
OpenAlexW3128013065

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.